National Audioconference on Operationalizing the OIG Pharmaceutical Compliance Guidance

PRESS RELEASE: National Pharma Congress Audioconference: Operationalizing the OIG Pharmaceutical Guidance - Grants, Consulting Agreements and Sales and Marketing
	Thursday, September 18, 2003 1:00 pm - 2:45 pm (Eastern) 12:00 pm - 1:45 pm (Central) 11:00 am - 12:45 pm (Mountain) 10:00 am - 11:45 am (Pacific) Sponsored by the Pharmaceutical Compliance Forum www.PharmaAudioconferences.com
PRESS RELEASE Contact: Paul Tunnecliff 800-684-4549 phone registration@hcconferences.com WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE(TM) -- SEPTEMBER 4, 2003: : The Pharma Congress 2003, November 12 - 14, 2003, in Washington, DC, PharmaCongress.com announced today the scheduling of a national audioconference on Operationalizing the OIG Pharmaceutical Guidance - Grants, Consulting Agreements and Sales and Marketing on Thursday, September 18, 2003 from 1:00 pm - 2:45 pm (Eastern). FEATURED FACULTY: Marc Farley, Esq., Assistant General Counsel and Compliance Officer, Berlex Laboratories, Inc., Montville, NJ Arjun Rajaratnam, Esq., Compliance Officer, Global Pharmaceuticals, GlaxoSmithKline, Research Triangle Park, NC James Sheehan, Esq., Assistant U.S. Attorney, Chief, Civil Division, Eastern District of Pennsylvania, Philadelphia, PA John Bentivoglio, Esq., Partner, Arnold and Porter and Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC (Moderator) LEARNING OBJECTIVES: To Provide an Overview of the Final OIG Compliance Program Guidance for Pharmaceutical Manufacturers To Discuss the Specific Impact on Compliance Program Organization and Structure as a Result of the OIG's Compliance Guidance To Review the Identified Risk Areas in the Compliance Guidance and the Potential Impact on the Pharmaceutical Industry To Explore Practical Initiatives Your Company can Pursue to Implement Provisions of the OIG Compliance Guidance To Specifically Assess the Implications of the Compliance Guidance to Grants, Consulting Agreements and Sales and Mark AUDIOCONFERENCE CONTINUING EDUCATION CREDIT AVAILABLE: Only Pharma Audioconferences offer 11 types of continuing education credit that can be applied for and approved online. The Following Extensive CEs: AAPC; ACCME; ACHE; ACMPE; ACPE; AHIMA; ANCC; CISSP/SSCP; HIMSS, HCCB; MCLE; and NASBA.. SPONSOR: THE PHARMACEUTICAL COMPLIANCE FORUM: The Audioconference is sponsored by the Pharmaceutical Compliance Forum (PCF). PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry, to promote effective corporate compliance programs. The organization is open to others in the industry, and has more than doubled its membership since it was founded. The members meet twice a year, for one to two days, focusing on open and informal sharing of compliance information, best practices and current developments in the field. SAVE THE DATE FOR THE PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS: Please save the date for the upcoming Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum, November 12 - 14, 2003, in Washington, DC, www.PharmaCongress.com, featuring the following keynote faculty: Thomas Abrams, Director, Division of Drug Advertising, Marketing & Communications, Food and Drug Administration, Rockville, MD Raymond Gilmartin, Chairman, President and CEO, Merck & Co., Inc., Whitehouse Station, NJ Thomas B. Leary, Esq., Commissioner, Federal Trade Commission, Washington, DC Michael Loucks, Esq., Chief of the Health Care Fraud Unit, Assistant U.S. Attorney, US Attorney's Office for the District of Massachusetts, Boston, MA Mark B. McClellan, MD, Ph.D., Commissioner of Food and Drugs, Food and Drug Administration, Rockville, MD Lewis Morris, Esq., General Counsel, Office Of Inspector General, Department of Health and Human Services, Washington, DC Dennis Nally, Chairman and Senior Partner, PricewaterhouseCoopers, New York, NY Thomas Scully, Administrator, Center for Medicare and Medicaid Services, Department of Health and Human Services, Washington, DC James Sheehan, Esq., Chief of the Civil Division, Assistant U.S. Attorney, US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA Janet Woodcock, MD, Director, Center for Drug Evaluation and Research , Food and Drug Administration, Rockville, MD AUDIOCONFERENCE REGISTRATION: The Audioconference Registration Fee is $345 per Site. No limit to number of attendees per site. You can register online at: http://www.PharmaAudioconferences.com Alternatively, you can download and print the Audioconference Registration Form from the website: http://www.pharmaaudioconferences.com/pcaudio20030918/regform.pdf The completed form can be faxed to 760-418-8084 or sent to: HIPAA Summit Audioconference Office 7790 Barberry Ave Yucca Valley CA USA 92284 FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS: Please email your request to: webmaster@PharmaAudioconferences.com.